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Abstract
We performed on-pump coronary artery bypass graft
surgery on a 54-year-old female, known case of chronic
Idiopathic Thrombocytopenic Purpura (ITP), hypertension
and dyslipidaemia who had presented to us with progressive
exertional shortness of breath and chest pain. The decision
of going on with CABG was made after two weeks of
preoperative treatment with prednisolone. Her platelet
counts pre-operatively and on the 4th post-operative day
were 135x109/L and 32x109/L. She had an unremarkable
post-operative recovery, without requiring whole blood or
platelet transfusions. We recommend preoperative steroid
treatment in patients with chronic ITP undergoing CABG. 
Introduction
Immune thrombocytopenic purpura (ITP) patients
are at high risk for bleeding complications, during and after
cardiac surgeries involving cardiopulmonary bypass. Every
year 58-66 per million new cases of adult chronic ITP are
diagnosed in the U.S.1 Comparable statistics for developing
regions are not available. About 30% of these patients have
antiphospholipid antibodies in their blood.2We describe the
case of a 58 year old female with chronic ITP who
underwent a successful surgical revascularization after
medical optimization with steroids.
Case Report
A 58-year-old female who was a known case of ITP,
presented with progressive exertional shortness of breath
and chest pain. She had a 25 year history of ITP,
hypertension and dyslipidaemia. She had previously tested
positive for anti-cardiolipin antibodies but the diagnosis of
antiphospholipid syndrome was not established due to the
absence of clinical findings. She did not have any successful
pregnancy. She had previously been treated with steroids
and her platelet counts were managed between 3x109/L and
150x109/L. With steroid treatment, angiography was
performed which showed 3 vessel coronary artery disease
(RCA 70%, LCX 80% and LAD 90%), requiring bypass
surgery. Her ITP was a major hindrance in proceeding with
CABG as she had a previous history of massive bleeding
requiring blood and platelet transfusions following tooth
extraction, 22 years ago. She was kept on 10 mg BD
prednisolone for two weeks and her platelet count was
stabilized above 100x109/L. Her preoperative platelet count
was 135x109/L and she had an unremarkable clinical
examination. After this optimization with steroid therapy
she underwent surgical revascularization with
cardiopulmonary bypass support. Three vascular bypass
grafts were established using the internal mammary artery
and the saphenous vein. Heparinization was maintained
during the grafting. The aortic cross clamp time was 30
minutes and total cardiopulmonary bypass time was 50
minutes. At the end of the procedure her platelet count was
33x109/L. On the first post operative day the platelets
dropped to 15x109/L. Prednisolone dose was increased to 30
mg but platelets were not transfused as there was no
evidence of active internal or external bleeding. She had a
prolonged ICU stay of three days, without major
complications. Her platelet count gradually improved to
32x109/L, and on fourth postoperative day she was shifted
out of the ICU. She had an uneventful post-operative stay
and was discharged from the service without requiring
blood or platelet transfusions. 
Discussion
Idiopathic thrombocytopenic purpura is described as
persistent thrombocytopenia with mucocutaneous bleeding
due to autoimmune destruction of the IgG coated platelets
by the reticuloendothelial system, predominantly in the
spleen and liver. Although antiphospholipid antibodies may
be present in these individuals but they are of less
significance in the absence of clinical findings.3 There are
conflicting results regarding the significance of
anticardiolipin antibody as an independent risk factor for
coronary heart disease but one of the recent study in this
respect has shown that high anticardiolipin antibody titers
are an independent risk factor for recurrent cardiac events.4
To date very few cases of patients with ITP
undergoing CABG have been reported, with a significant
part of the literature being in Japanese and no clear
guidelines exist for preoperative management of such
patients. Inoue and co-workers reported an ITP patient who
underwent off-pump CABG with pre-operative IgG
therapy.5 The patient did not require any platelet transfusion
post-operatively. Mathew and associates reported three
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cases of ITP undergoing CABG using cardiopulmonary
bypass with preoperative IgG therapy.6 Platelet transfusion
was required in two out of the three patients operated. A
study by Christiansen has suggested the use of IgG in
patients with ITP undergoing cardiac surgery with platelet
counts below 80x109/l.7 But it did not significantly affect
the postoperative platelet transfusion requirement.
Splenectomy is the traditional second line therapy in
patients who fail to respond to steroids and IgG therapy.1
This has been described as a treatment option along with
cardiac surgery in such patients.8 Response to splenectomy
takes several days and failure of treatment is reported in
about one-third of the patients. Moreover, this is a high risk
procedure in such patients. Jubelirer9 has described two
patients who underwent successful surgical
revascularization without undergoing splenectomy.
Bleeding was managed using platelet transfusions only.
Our patient had a good response to prednisolone
treatment and therefore it was selected as the pre-operative
treatment to raise her platelet counts. Platelet transfusion was
not required perioperatively. She was splenectomized 12 years
ago but it had not improved her condition. IgG therapy is very
expensive in this part of the world. It is difficult for the patients
to afford due to the health care system setting of Pakistan and
that the response to IgG therapy is transient and varies.
Therefore we recommend preoperative steroid
treatment as an effective alternative to IgG therapy in patients
with chronic ITP undergoing CABG and that the use of the off-
pump technique should be practiced only if it is workable.
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